Fortitude Family Office »

Edgewise Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9k 160 18.24
2023-12-31 $1.8k 160 10.94

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Jpmorgan Ultra-short Income Etf Ultra Short Income Fund Etf (JPST)
Kkr & Co Stock (KKR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Vanguard Ftse Emerging Markets Etf Etf (VWO)

View all positions for Fortitude Family Office

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
FMR
Baker Bros. Advisors
BlackRock
Vanguard Group
Viking Global Investors
Frazier Life Sciences Management
Cormorant Asset Management
Deerfield Management Company
Citadel Advisors
Paradigm Biocapital Advisors
Perceptive Advisors
VR Adviser
Henderson Group

View all funds holding Edgewise Therapeutics